Electric bandage compared with usual care for long-lasting leg wounds in Veterans
Tests the exciflex electric bandage against usual care in Veterans with leg wounds.
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Cleveland, United StatesSee the site
- Trial code
- Registry title
- Exciflex Electroceutical Banadage for Chronic Wound Therapy
- Status
- Recruiting
- People taking part
- 16 people, planned
- Started
- 5 Oct 2022
- Expected to end
- 30 Sept 2029
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- exciflex
- Record updated
- 10 August 2026
Who can take part
The trial is looking for adults with chronic wounds treated at the Louis Stokes Cleveland VA Medical Center. The main groups are Veterans with spinal cord injury and Veterans with diabetes who get wound care.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Chronic wounds, mainly ischemic wounds (wounds with poor blood flow) of the legs or feet.
- Main reasons for not taking part
- Pregnancy
- Age under 18 years
Show the full registry criteria (4)Hide the full registry criteria
Who can take part
- All participants with chronic wounds treated at LSCVAMC will be potentially eligible for the study
- Primary target populations will include Veterans with SCI who are inpatients or residents of the on-site Long-Term Care Unit and Veterans with diabetes being followed by the Podiatry Service for wound care
Who cannot take part
- In addition to meeting the general inclusion criteria noted above, further exclusion criteria relating to clinical factors include:
- Pregnancy
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
This trial is currently available in United States.
- Louis Stokes VA Medical Center, Cleveland, OHCleveland, United StatesContact: Katie R Schwartz, RNTaking people
About the trial
What the trial wants to find out
Objectives: The study objective is to carry a pilot clinical assessment comparing the exciflex bandage to standard of care (SoC) for ischemic wounds and will involve participants who are Veterans with lower extremity ischemic wounds.
Read full original descriptionShow less
Research Plan: The study will employ a randomized repeated measures design to assess the therapeutic effectiveness of exciflex in clinical use.
Methodology: All participants with chronic ischemic wounds treated at Louis Stokes Cleveland VA Medical Center (LSCDVAMC) will be potentially eligible for the study. Primary target populations will include Veterans with SCI who are inpatients or residents of the on-site Long Term Care Unit and Veterans with diabetes being followed by the Podiatry Service for wound care. In addition to meeting the general inclusion criteria noted above, further exclusion criteria relating to clinical factors include; (1) Age less than 18 years and (2) Pregnancy.
Clinical Significance: Chronic ischemic wounds fail to heal normally and are a major challenge in the long-term care of many Veterans. The exciflex bandage can improve outcomes and lower cost by automatically delivering electrotherapy without disturbing the wound dressing for up to seven days, unless indicated. The overall study goal is to complete pre-market testing and evaluation of the exciflex bandage system.
The 2 groups in the trial
- Group A: Wound treated using exciflexTreatment being tested
Intervention treated wounds in Group A participants will be covered using the exciflex bandage which will be activated to deliver ES using a 10% duty cycle, i.e. ES will be active for 1 minute out of every 10 minutes. ES will be delivered for up to 10 weeks or until the wound is healed for 3 days. The exciflex bandage will be changed when indicated clinically or every 5 days, whichever is sooner. At each bandage change, wound status monitored as described above, specifically multi-modal digital imaging and wound swabs. The exciflex power/control module will then be transferred to a new sterile flexible substrate and the exciflex bandage reapplied to the wound.
Treatment: exciflex
- Group B: Wound treated using standard of careNo study treatment, for comparison
Control treated wounds in Group B participants will be covered with an exciflex bandage that is not activated . The bandage will be used for up to 10 weeks or until the wound is healed for 3 days. The bandage will be changed when indicated clinically or every 5 days, whichever is sooner. At each bandage change, wound status monitored as described above, specifically multi-modal digital imaging and wound swabs . A fresh sterile inactive exciflex bandage will then be reapplied to the wound.
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Toward Smart Personalized Electrotherapy for Enhanced Healing of Chronic Wounds
- Plain-language title
- Electric bandage compared with usual care for long-lasting leg wounds in VeteransGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT04887688, who can take part
- Record updated
- 10 August 2026